MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii.
Toxoplasma gondii is a widespread apicomplexan parasite that can cause severe disease in its human hosts. The ability of T. gondii and other apicomplexan parasites to invade into, egress from, and move between cells of the hosts they infect is critical to parasite virulence and disease progression....
Main Authors: | Anne Kelsen, Robyn S Kent, Anne K Snyder, Eddie Wehri, Stephen J Bishop, Rachel V Stadler, Cameron Powell, Bruno Martorelli di Genova, Pramod K Rompikuntal, Martin J Boulanger, David M Warshaw, Nicholas J Westwood, Julia Schaletzky, Gary E Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-05-01
|
Series: | PLoS Biology |
Online Access: | https://doi.org/10.1371/journal.pbio.3002110 |
Similar Items
-
mSphere of Influence: Deciphering purine auxotrophy in protozoan parasites
by: Bruno Martorelli Di Genova
Published: (2024-04-01) -
Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design
by: Dihia Moussaoui, et al.
Published: (2023-06-01) -
Blocking Palmitoylation of Toxoplasma gondii Myosin Light Chain 1 Disrupts Glideosome Composition but Has Little Impact on Parasite Motility
by: Pramod K. Rompikuntal, et al.
Published: (2021-06-01) -
A small-molecule inhibitor of T. gondii motility induces the posttranslational modification of myosin light chain-1 and inhibits myosin motor activity.
by: Aoife T Heaslip, et al.
Published: (2010-01-01) -
Are protozoan metacaspases potential parasite killers?
by: Picot Stephane, et al.
Published: (2011-02-01)